RAA primer pair and probe combination for detecting mycoplasma hyopneumoniae and kit thereof
By designing specific RAA primer pairs and probe combinations for Mycoplasma swelling pneumoniae, the problem of insufficient detection sensitivity and specificity in RAA technology is solved, and rapid and high specificity detection under 42°C is achieved, suitable for field Diagnosis improves the visualization and accuracy of the detection.
Patent Information
- Application Number
- CN202411345572.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-08-22
- Filing Date
- 2024-09-26
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-09-26
AI Technical Summary
The existing recombinase-mediated isothermal amplification technology (RAA) has sensitivity and specificity problems in primer and probe design, resulting in missed tests and false positives, limiting its widespread use in clinical applications.
A specific RAA primer pair and probe combination for Mycoplasma swelling pneumoniae was designed, including Mhp-p46-F and Mhp-p46-R primers, as well as Mhp-p46-Probe probes, was designed for fluorescence detection by a portable blue light meter. Achieve rapid and high specificity detection.
It realizes rapid, sensitive and specific detection of Mycoplasma swine pneumoniae, and can complete nucleic acid amplification under constant temperature of 42℃. It is suitable for on-site diagnosis, reduces detection cost and complexity, and improves the visualization and accuracy of the detection.
Smart Images

Figure CN118995977A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of gene detection of animal diseases, and specifically relates to a RAA primer pair and probe combination and a kit for detecting Mycoplasma hyopneumoniae, that is, to provide a primer pair and a probe for rapid detection of recombinase-mediated isothermal amplification (RAA) of Mycoplasma hyopneumoniae, and a kit using the primer pair and the probe. Background Art
[0002] Mycoplasma pneumonia of swine (MPS), also known as swine enzootic pneumonia and swine asthma, is a chronic respiratory infectious disease of pigs with high morbidity and low mortality caused by Mycoplasma hyopneumoniae (Mhp). MPS only infects pigs, regardless of breed, age and gender. Suckling pigs and weaned piglets are the most susceptible, with high morbidity and mortality. Sows in late pregnancy and lactation are also susceptible. Fattening pigs are less susceptible, often showing chronic infection and latent infection. The prevalence and existence of MPS have long plagued the healthy development of the pig industry around the world, causing very serious economic losses to the world's pig industry. At present, the methods commonly used for the prevention and control of MPS are to improve the level of feeding management and establish a sound biosafety system. Therefore, early diagnosis and real-time monitoring of the pathogen are crucial for the prevention and control of the disease, and are of great significance to the development and sustainable and healthy development of the pig industry.
[0003] Recombinase-aided amplification (RAA) is a new isothermal in vitro nucleic acid amplification technology. This technology can achieve rapid amplification of nucleic acids at a constant temperature of 37-42°C by using recombinase, single strand DNA binding protein (SSB) and DNA polymerase. It is suitable for rapid diagnosis in clinical sites. It is an isothermal amplification technology with independent intellectual property rights in my country and has a promising prospect for promotion and application in the field of nucleic acid detection.
[0004] However, RAA technology has very strict requirements for the design of probes and primers. Primers are the key factor in determining the sensitivity of RAA reactions. Unsuitable primer pairs will seriously affect the sensitivity of the reaction, resulting in missed detection of positive samples in clinical practice. Probes are the key factor in the specificity of RAA reactions. Unsuitable probes will produce nonspecific fluorescence and false positives; and non-conservative probes will also lead to missed detection of positive samples in clinical practice. Therefore, the design of primers and probes for this technology is the main limiting factor for the clinical application of RAA technology.
[0005] It is worth noting that by designing exo probes and adding FAM fluorescent groups to the reaction system, the amplification products can be visualized under the corresponding excitation wavelength with the help of a convenient blue light instrument. This technology has the advantages of low cost, high sensitivity, good repeatability, simple operation, and visualized results. It is suitable for the field of rapid nucleic acid detection, especially in resource-limited environments, grassroots and on-site instant detection. Summary of the invention
[0006] The purpose of the present invention is to provide a RAA primer pair and probe combination and a kit for detecting Mycoplasma hyopneumoniae, so as to complete the simple, rapid, sensitive and specific detection of Mhp.
[0007] The present invention first provides a RAA primer pair and probe for detecting Mycoplasma hyopneumoniae, and the sequence information thereof is as follows:
[0008] Mhp-p46-F: 5′-TTTGTAACAATTACTGGACTTACTAAAATTGTATT-3′ (SEQ ID NO: 1);
[0009] Mhp-p46-R: 5′-AGTTGCTGTTGAAGTTCTTCGGGTTTTAAT-3′ (SEQ ID NO: 2);
[0010] The sequence of Mhp-p46-Probe is as follows:
[0011] 5′-GGTAGCTTTGCTTTTAGTTCGTTTTCGACTTTTGATCTAGATGCTTTA-3′ (SEQ ID NO: 3);
[0012] The probe Mhp-p46-Probe has a FAM luminescent group labeled with the 31st base T from the 5′ end, a tetrahydrofuran THF replaced with the 32nd base T, a BHQ1 quenching group labeled with the 33rd base T, and a C3-spacer blocking modification performed on the 3′ end.
[0013] The primer pair and probe provided by the present invention can be used to prepare a kit for detecting Mycoplasma hyopneumoniae;
[0014] In another aspect, the present invention provides a RAA kit for detecting Mycoplasma hyopneumoniae, wherein the kit comprises the above-mentioned RAA primer pair and probe.
[0015] The kit also comprises a reagent system suitable for recombinase-mediated isothermal amplification reaction and a fluorescence-based reaction unit.
[0016] The reagent system comprises a reaction buffer, nuclease-free water and magnesium acetate.
[0017] The fluorescence basic reaction unit comprises a single-stranded DNA binding protein, a recombinase and a polymerase.
[0018] The RAA primer pair and probe for detecting Mycoplasma hyopneumoniae provided by the present invention can detect Mycoplasma hyopneumoniae specifically and with high sensitivity. The detection kit using the primer pair and the probe can be visually judged by naked eyes through a portable blue light instrument, and can truly realize portable visual rapid nucleic acid detection. It has the characteristics of being simple and rapid, sensitive in response, and having good specificity, and has broad application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] Figure 1 :Comparison and analysis of Mycoplasma hyopneumoniae,
[0020] Figure 2 :Comparison and analysis of Mycoplasma hyopneumoniae and Mycoplasma floccosum,
[0021] Figure 3 : Screening diagram of RAA primers for Mycoplasma hyopneumoniae, wherein (A): a schematic diagram of the first round of primer screening; (B): a diagram of the first round of downstream primer screening results; (C): a diagram of the first round of upstream primer screening results; (D): a schematic diagram of the first round of primer screening; (E): a diagram of the second round of downstream primer screening results; (F): a diagram of the second round of upstream primer screening results; (G): a schematic diagram of the third round of primer screening; (H): a diagram of the third round of downstream primer screening results; (I): a diagram of the third round of upstream primer screening results.
[0022] Figure 4 : Specificity validation diagram of the RAA method for Mycoplasma hyopneumoniae, where (A): real-time fluorescence Mhp-RAA amplification results, (B): Mhp-RAA visualization results; in the picture, 1: Mycoplasma hyopneumoniae, 2: Streptococcus suis, 3: Klebsiella pneumoniae, 4: Glaseria suis, 5: Actinobacillus pleuropneumoniae, 6: Staphylococcus aureus, 7: Pseudomonas aeruginosa, 8: Salmonella, 9: Escherichia coli, 10: negative control group.
[0023] Figure 5 : Sensitivity validation diagram of Mycoplasma hyopneumoniae RAA, (A): Mhp-qPCR sensitivity test results and statistical analysis results; (B): Real-time fluorescence Mhp-RAA sensitivity test results and statistical analysis results; (C): Visualization Mhp-RAA sensitivity test results and statistical analysis results; 1:10 6 copies / μL APC, 2:10 5 copies / μL APC, 3:10 4 copies / μL APC, 4:10 3copies / μL APC, 5:10 2 copies / μL APC, 6:10 1 copies / μL APC, 7:10 0 copies / μL APC, 8: negative control. DETAILED DESCRIPTION
[0024] The present invention is described in detail below in conjunction with embodiments and drawings.
[0025] Example 1: Design of primers and probes
[0026] The present invention compares the representative reference strains of Mycoplasma hyopneumoniae in Genbank and selects the conserved region in the Mhp-p46 gene as the target ( Figure 1 Since the p46 gene of Mycoplasma hyopneumoniae is highly similar to the p46 gene of Mycoplasma suis, the p46 gene sequence of Mycoplasma suis was also compared ( Figure 2 ). The region with great differences between the two was selected for probe design. Through rigorous analysis of the target sequence, the region that can meet the amplification requirements and the requirements of conservation and specificity was selected as the target, and the exo probe Mhp-p46-Probe (5′-GGTAGCTTTGCTTTTAGTTCGTT TTCGACTTTTGATCTAGATGCTTTA-3′) was designed.
[0027] The probe Mhp-p46-Probe is labeled with a FAM luminescent group at the 31st base T from the 5′ end, the 32nd base T is replaced by tetrahydrofuran THF, the 33rd base T is labeled with a BHQ1 quenching group, and the 3′ end is modified with a C3-spacer blocking.
[0028] 5′-GGTAGCTTTGCTTTTAGTTCGTTTTCGACT(FAM-dT)(THF)(BHQ1-dT)GATCTAGATGCTTTA[C3-Spacer]-3′.
[0029] Subsequently, the RAA primer pairs for Mycoplasma hyopneumoniae were designed and screened. In addition to the conventional RAA primer design principles, the 3′ end of the candidate primers must be conservative, avoiding the presence of palindromic sequences and stem-loop structures, and no more than 5 repeat sequences.
[0030] According to the above principles, the present invention designed 34 candidate primers and carried out three rounds of primer screening.
[0031] In order to ensure that each screening primer can react at the same time, magnesium acetate B Buffer is added to the lid of the reaction tube during screening, and then centrifuged to allow the reactions in each reaction tube to proceed simultaneously. The specific system (25 μL) includes:
[0032]
[0033] Using BioRad CFX96 TM The experiment was carried out using a Touch real-time fluorescence quantitative PCR instrument, and the fluorescence detection program was set as follows: constant temperature at 42°C, FAM channel fluorescence values were collected every 1 min, for a total of 30 cycles.
[0034] The screening criteria for each screening is to select candidate primers corresponding to the curve with strong total fluorescence signal intensity and short starting time of amplification peak, which ensures that the primers screened not only have higher sensitivity but also can complete the detection in a shorter time.
[0035] First, the first round of screening is to roughly determine the location of the primer. The length of the first round of screening candidate primers is 30nt. The present invention respectively designs 5 upstream (F1216-1245, F1206-1235, F1172-1202, F1158-1187, F1132-1162) and 5 downstream candidate primers (R958-987, R992-1021, R1005-1034, R1046-1075, R1060-1089) covering the entire target area ( Figure 3 A). First, the upstream primer was fixed, and all the downstream primers R958-987, R992-1021, R1005-1034, R1046-1075, and R1060-1089 were screened. Then, the most suitable first-round downstream primer R1046-1075 was obtained. Then, the downstream primer was used to screen all the upstream primers F1216-1245, F1206-1235, F1172-1202, F1158-1187, and F1132-1162, and the most suitable primer pair F1206-1235, R1046-1075 ( Figure 3 B, Figure 3 C).
[0036] Since the first round of screening has roughly determined the positions of the primers, the purpose of the second round of screening of the present invention is to accurately determine the positions of the primers. The best primers obtained in the first round of screening were used as the standard, the primer length was kept at 30 nt, and the position was continuously moved forward or backward by 1-3 nt to design 8 second-round upstream primers (F1211-1240, F1210-1239, F1208-1237, F1207-1236, F1206-1235, F1203-1232, F1202-1231, F1200-1229) and 8 downstream primers (R1044-1073, R1046-1075, R1047-1076, R1048-1077, R1053-1082, R1054-1083, R1055-1084, R1056-1085) ( Figure 3 D). First, the upstream primer F1206-1235 was fixed, and all the downstream primers R1044-1073, R1046-1075, R1047-1076, R1048-1077, R1053-1082, R1054-1083, R1055-1084, and R1056-1085 were screened. Then the optimal second round downstream primer R1053-1082 was obtained, and then all upstream primers were screened using the downstream primer F1211-1240, F1210-1239, F1208-1237, F1207-1236, F1206-1235, F1203-1232, F1202-1231, F1200-1229, and the optimal second round primer pair F1203-1232, R1053-1082 ( Figure 3 E, Figure 3 F).
[0037] Now that the position of the primer pair has been determined, the purpose of the third round of screening is to further determine the length of the primer. The method used is to fix the position of the best primer in the second round and add bases one by one at the 3′ end. The length of the primer ranges from 30 to 36 nt. Six upstream primers (F1203-1232, F1202-1232, F1201-1232, F1200-1232, F1199-1232, F1198-1232) and six downstream primers (R1053-1082, R1053-1083, R1053-1084, R1053-1085, R1053-1086, R1053-1087) were designed respectively. Figure 3G). First, the upstream primer F1203-1232 was fixed, and all the downstream primers R1053-1082, R1053-1083, R1053-1084, R1053-1085, R1053-1086, and R1053-1087 were screened. Then, the most suitable third round downstream primer R1053-1082 was obtained, and then the downstream primer was used to screen all the upstream primers F1203-1232, F1202-1232, F1201-1232, F1200-1232, F1199-1232, and F1198-1232, and the most suitable upstream primer F1198-1232 was obtained.
[0038] After three rounds of screening of 34 candidate primers, the optimal primer pair for RAA reaction was finally obtained: F1198-1232, R1053-1082 (Mhp-p46-F, Mhp-p46-R) ( Figure 3 H, Figure 3 I). Since the screening criteria for each screening are to select candidate primers corresponding to the curve with strong total fluorescence signal intensity and short amplification peak starting time, Mhp-p46-F and Mhp-p46-R not only have higher sensitivity but also can complete the detection in a shorter time.
[0039] The sequences of the upstream primer Mhp-p46-F and the downstream primer Mhp-p46-R are as follows:
[0040] Mhp-p46-F: 5′-TTTGTAACAATTACTGGACTTACTAAAATTGTATT-3′;
[0041] Mhp-p46-R: 5′-AGTTGCTGTTGAAGTTCTTCGGGTTTTAAT-3′.
[0042] Example 2: Specific detection of screened primer probes
[0043] In order to verify the specificity of the present invention, in this example, nucleic acids of Mycoplasma hyopneumoniae, Streptococcus suis, Klebsiella pneumoniae, Glaseria suis, Actinobacillus pleuropneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella typhimurium and Escherichia coli were extracted as reaction templates according to the instructions of the DNA extraction reagent, and a negative control was set.
[0044] The specific system (25 μL) for the Mycoplasma hyopneumoniae fluorescent RAA specificity assay includes:
[0045]
[0046]
[0047] Using BioRad CFX96 TM The experiment was carried out using a Touch real-time fluorescence quantitative PCR instrument, and the fluorescence detection program was set as follows: constant temperature at 42°C, FAM channel fluorescence values were collected every 1 min, for a total of 30 cycles.
[0048] Figure 4 The results in A show that the experimental group corresponding to Mycoplasma hyopneumoniae DNA showed a specific fluorescence detection curve, while other bacterial pathogens and the negative control group did not show specific amplification curves. Figure 4 The results of B show that the test group corresponding to the Mycoplasma hyopneumoniae DNA showed specific green fluorescence, while the visualization results of other bacterial pathogens and negative controls were colorless. The results show that the primer pair and probe combination used in the present invention can achieve specific detection of Mycoplasma hyopneumoniae, and does not cross-react with other related bacterial pathogens, with good specificity.
[0049] Example 3: Verification of RAA sensitivity of Mycoplasma hyopneumoniae
[0050] In order to test the sensitivity of the selected primer pairs and probe combinations, 10 6 -10 0 copies / μL Mhp-p46 positive standard plasmid (artificial positive control, APC), and RAA nucleic acid amplification was performed according to the above-mentioned sample addition method. A positive standard plasmid named pEASY-Blunt-Mhp-p46 was constructed. By calculating the dilution to 10 6 Then dilute 10 times to 10 copies / μL 5 copies / μL, 10 4 copies / μL, 10 3 copies / μL, 10 2 copies / μL, 10 1 copies / μL, 10 0The RAA nucleic acid amplification was performed according to the above-mentioned sample addition method, and the qPCR method in the published literature (Marois, C., Dory, D., Fablet, C., Madec, F., Kobisch, M., 2010. Development of a quantitative Real-Time TaqMan PCR assay for determination of the minimal dose of Mycoplasma hyopneumoniae strain 116 required to induce pneumonia in SPF pigs. J Appl Microbiol 108, 1523-1533.) was used for comparison. The test results are shown in Figure 5 shown.
[0051] like Figure 5 As shown in Figures AC, the RAA primer and probe combination designed by the present invention has a strong sensitivity. The detection limit of Mhp-qPCR is 10 copies / μL, and the real-time fluorescence Mhp-RAA detection method and the visualization Mhp-RAA detection method established by the present invention can also detect 10 copies / μL. By calculating and analyzing 8 repetitions using SPSS software, the sensitivity of the Mhp-qPCR detection method can reach 29 copies / μL (95% confidence interval), while the sensitivity of the real-time fluorescence Mhp-RAA detection method can reach 18 copies / μL (95% confidence interval). It is worth noting that the sensitivity of the visualization Mhp-RAA detection method can also reach 29 copies / μL (95% confidence interval).
[0052] Example 4: Preparation of a kit for detecting Mycoplasma hyopneumoniae using real-time fluorescence RAA method
[0053] This embodiment provides a fluorescent RAA kit for detecting Mycoplasma hyopneumoniae. The kit comprises a reagent system suitable for recombinase-mediated isothermal amplification reaction and a basic reaction unit.
[0054] Wherein, the reagent system specifically includes reaction buffer, nuclease-free water, and magnesium acetate;
[0055] The basic reaction unit specifically comprises a single-stranded DNA binding protein, a recombinase and a polymerase, and the basic reaction unit exists in the form of a lyophilized powder.
[0056] The specific system (25 μL) of the fluorescent RAA kit for detecting Mycoplasma hyopneumoniae includes:
[0057]
[0058] The operation method of the real-time fluorescence RAA detection method for detecting Mycoplasma hyopneumoniae using the above-mentioned detection kit specifically comprises the following steps:
[0059] (1) extracting the DNA of the sample to be tested by conventional methods;
[0060] (2) Using the extracted DNA as a template, RAA amplification was performed at a constant temperature of 42°C for 30 min;
[0061] (3) Result determination
[0062] The reaction conditions of the above RAA detection method are constant temperature amplification for 30 minutes at 42° C. The extracted DNA is used as a template, and the RAA primers and probes for detecting Mycoplasma hyopneumoniae in the kit and corresponding reagents are added to form a RAA reaction system for amplification.
[0063] Example 5: Detection and verification of clinical samples
[0064] A total of 108 clinical samples were collected, and the 108 clinical samples to be tested were extracted according to the instructions of the DNA extraction reagent, and the extracted DNA was stored at -20°C.
[0065] The test kit of Example 4 was used for detection, and the clinical sample was detected by the qPCR method in the published literature for comparison. The test results are shown in Table 1 below.
[0066] Table 1: Test results of clinical samples
[0067]
[0068] The results showed that both real-time fluorescence Mhp-RAA and Mhp-qPCR could detect 22 positive samples in 108 clinical samples, with a coincidence rate of 98%; visual Mhp-RAA could detect 21 positive samples, with a coincidence rate of 99% with Mhp-qPCR. The Kappa values of real-time fluorescence and visual Mhp-RAA and Mhp-qPCR were 0.943, P < 0.001 and 0.971, P < 0.001, respectively.
[0069] In summary, the present invention designs a primer pair and probe for real-time fluorescent RAA for the Mhp-p46 gene, and screens out upstream and downstream primers Mhp-p46-F, Mhp-p46-R and probe Mhp-p46-Probe suitable for rapid detection of RAA. The real-time fluorescent RAA kit for detecting Mycoplasma hyopneumoniae based on the primer pair and probe described in the present invention only needs to react for 30 minutes under a constant temperature of 42°C to complete. The entire reaction process has low requirements for instruments and equipment, short time consumption, simple operation, and the results can be visualized with the naked eye, which is more suitable for grassroots on-site diagnosis and instant detection. It truly realizes portable rapid nucleic acid detection, and can provide technical support for rapid diagnosis, real-time monitoring and prevention and control of Mycoplasma hyopneumoniae.
Claims
1. A RAA primer pair and probe for detecting Mycoplasma hyopneumoniae, characterized in that: The upstream primer of the primer pair is SEQ ID NO: 1, the downstream primer is SEQ ID NO: 2, and the probe is SEQ ID NO:
3.
2. The primer pair and probe according to claim 1, characterized in that: The 31st base T of the 5' end of the probe is labeled with a FAM luminescent group, the 32nd base T is replaced by tetrahydrofuran THF, the 33rd base T is labeled with a BHQ1 quenching group, and the 3' end is modified with a C3-spacer blocking.
3. Use of the primer pair and probe according to claim 1 or 2 in the preparation of a kit for detecting Mycoplasma hyopneumoniae.
4. The use according to claim 3, characterized in that The kit is a RAA kit.
5. A RAA kit for detecting Mycoplasma hyopneumoniae, characterized in that: The kit comprises the primer pair and probe according to claim 1 or 2.
6. The RAA kit according to claim 5, characterized in that The kit also comprises a reagent system suitable for recombinase-mediated isothermal amplification reaction and a fluorescence-based reaction unit.
7. The RAA kit according to claim 6, characterized in that The reagent system comprises a reaction buffer, nuclease-free water and magnesium acetate.
8. The RAA kit according to claim 6, characterized in that The fluorescent basic reaction unit comprises a single-stranded DNA binding protein, a recombinase and a polymerase.
Citation Information
Patent Citations
Real-time fluorescence PCR detection reagent kit for mycoplasma hyopneumoniae of pigs and purpose of real-time fluorescence PCR detection reagent kit
CN106701942A
Mycoplasma hyopneumoniae nfo-RPA detection kit and preparation method thereof
CN114480684A
RAA primer pair, probe combination and kit for detecting swine Gleisseria
CN116694789A
Primer pair and probe set for detecting actinobacillus pleuropneumoniae
CN119193869A
Cited By
Molecular beacon probe for recombinase-mediated isothermal amplification detection technology, primer combination thereof, RAA method and application
CN119464458A
